M&A Deal Summary

SELLAS Life Sciences Group Acquires Galena Biopharma

On August 8, 2017, SELLAS Life Sciences Group acquired life science company Galena Biopharma

Acquisition Highlights
  • This is SELLAS Life Sciences Group’s 1st transaction in the Life Science sector.
  • This is SELLAS Life Sciences Group’s 1st transaction in the United States.
  • This is SELLAS Life Sciences Group’s 1st transaction in California.

M&A Deal Summary
Date 2017-08-08
Target Galena Biopharma
Sector Life Science
Buyer(s) SELLAS Life Sciences Group
Deal Type Merger
Advisor(s) Canaccord Genuity (Financial)
Paul Hastings (Legal)

Target

Galena Biopharma

San Ramon, California, United States
Galena Biopharma, Inc. is a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

SELLAS Life Sciences Group

New York, New York, United States
Category Company
Founded 2012
Sector Life Science
Employees16
Revenue 1M USD (2022)
DESCRIPTION

SELLAS Life Sciences Group is a development-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. SELLAS Life Sciences Group was founded in 2012 and is based in New York City.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Merger) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2017) 1 of 1
Mergr

Product

Company

Legal